Abstract: A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents into the skin containing at least two biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and a dihydric and/or polyhydric alcohol is provided.

Abstract: A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents into the skin containing at least two biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and a dihydric and/or polyhydric alcohol is provided. Also disclosed are compositions that further contain a cosmetic and/or pharmaceutical agent, along with the preparation and use thereof.

Abstract: A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents into the skin containing at least two biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and a dihydric and/or polyhydric alcohol is provided. Also disclosed are compositions that further contain a cosmetic and/or pharmaceutical agent, along with the preparation and use thereof.

Abstract: A method is provided for improving the appearance of nails of a patient wherein a composition is topically applying to the patient's nail(s) exhibiting symptoms of at least one condition selected from the group consisting of onycholysis, onychoschizia or onychorrhexis and wherein the composition contains one or more biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and/or a dihydric and/or polyhydric alcohol is provided.

Abstract: Solid oral composition for the treatment or prophylaxis of potassium and magnesium deficiency in skeletal and cardiac muscle containing about 3 to about 50 milliequivalent bioavailable potassium, about 0.1 to about 25 milliequivalent bioavailable magnesium, and a milliequivalent ratio of potassium to magnesium between about 2:1 and about 14:1, where the potassium is in a controlled release form, and methods of treating or preventing potassium and magnesium deficiency by oral administration of such compositions.

Abstract: A gel formation for oral administration having improved palatability comprising an effective hypocholesterolaemic amount of a uniform gelled dispersion of(a) between about 8 and about 20 percent by weight of a particulate, pharmaceutically acceptable, sparingly crosslinked non-digestible quaternary ammonium substituted polysytrene anion exchange resin having an average particle size below about 100 microns;(b) between about 4 and about 16 percent by weight of a pharmaceutically acceptable gelatin;(c) between about 0.015 and about 10 percent by weight of a natural or synthetic pharmaceutically acceptable sweetener;(d) between about 0.05 and about 2 percent by weight of a pharmaceutically acceptable organic acidulent;(e) between about 0.05 and about 5 percent by weight of one or more pharmaceutically acceptable flavoring or coloring agents or mixtures thereof; and(f) the remainder water.

Abstract: Salts and low molecular weight organic compounds are more efficiently separated from aqueous liquids by passing the liquid downwardly through a gel-type strong acid cation exchange resin, and eluting the resin. In a preferred embodiment, animal wastes and/or cheese whey are separated into usable components by removing insoluble organic material, then removing soluble proteins and/or enzymes by ion exchange with a macroporous weak base anion exchange resin, and then separating salts and nonionic organic compounds as above.

Abstract: Cured resins having excellent thermal and abrasion resistance and improved processability are provided by the addition polymerization of a compound having isocyanurate moieties, imide and/or amic acid moieties and ethylenically unsaturated moieties. An example of such a compound is the reaction product of an unsaturated cyclic anhydride such as maleic anhydride, an organic polyisocyanate such as a polymeric methylene phenyl polyisocyanate and water.

Abstract: Cellular resin bodies having apparent density less than about 30 pounds per cubic foot, where the resin has highly crosslinked three-dimensional ethylenic polymer structure having amic acid groups and/or cyclic imide linkages, are made by reaction of polyisocyanates with certain polymerizable ethylenically unsatured dicarboxylic acid cyclic anhydrides illustrated by maleic anhydride, and water. Mixture of the reactants and heating cause chemical interaction, evolution of carbon dioxide, ethylenic polymerization of intermediate reaction product, crosslinking, foaming and hardening of the resin. Cell formation is caused by carbon dioxide and water vapor in the resin reaction product. Resin foam products are infusible and insoluble in usual solvents and resist ignition and burning in air.